Evidence-based Healthcare最新文献

{"title":"High-quality nutrition counselling for hypercholesterolemia by public health nurses in rural areas does not affect total blood cholesterol","authors":"","doi":"10.1016/S1462-9410(03)00072-X","DOIUrl":"https://doi.org/10.1016/S1462-9410(03)00072-X","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"7 4","pages":"187-189"},"PeriodicalIF":0.0,"publicationDate":"2005-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/S1462-9410(03)00072-X","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71720835","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No association between mobile phone usage and development of acoustic neuroma","authors":"L. Hardell","doi":"10.1016/J.EHBC.2004.05.007","DOIUrl":"https://doi.org/10.1016/J.EHBC.2004.05.007","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"280 1","pages":"213-215"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"77897745","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hormone replacement therapy is not safe for breast cancer survivors","authors":"R. Vassilopoulou-sellin","doi":"10.1016/J.EHBC.2004.05.004","DOIUrl":"https://doi.org/10.1016/J.EHBC.2004.05.004","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"11 1","pages":"224-226"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73607736","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Laparoscopic hysterectomy is not cost effective compared with vaginal hysterectomy","authors":"B. Crawford","doi":"10.1016/J.EHBC.2004.05.014","DOIUrl":"https://doi.org/10.1016/J.EHBC.2004.05.014","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"71 1","pages":"197-199"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"86356505","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Link between diagnostic X-rays and cancer uncertain☆","authors":"J. Cameron","doi":"10.1016/J.EHBC.2004.05.011","DOIUrl":"https://doi.org/10.1016/J.EHBC.2004.05.011","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"1 1","pages":"205-206"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"73021494","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Retaplase plus abciximab improves non-fatal outcomes, but not overall survival in people with diabetes and acute ST-segment elevation myocardial infarction","authors":"Victor Serebruany MD, PhD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.001","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.001","url":null,"abstract":"<div><h3>Question</h3><p>In people with diabetes and ST-segment elevation myocardial infarction, is half-dose reteplase plus abciximab more effective than reteplase alone?</p></div><div><h3>Study design</h3><p>Secondary analysis of multicentre randomised controlled trial.</p></div><div><h3>Main results</h3><p>For mortality at 30 days or 1 year, there was no significant difference between groups (see Table 1). Reteplase plus abciximab significantly reduced the risk of reinfarction, or recurrent ischaemia or angina compared with reteplase alone.<span><div><div><table><tbody><tr><td><strong>Table 1</strong> Clinical outcomes for people with diabetes and ST-segment myocardial infarction.</td></tr><tr><td></td><td>Reteplase alone (<em>n</em>=1299)</td><td>Half-dose reteplase plus abciximab (<em>n</em>=1334)</td><td><em>P</em> value</td></tr><tr><td>Death within 30 days</td><td>8.8%</td><td>8.2%</td><td>0.57</td></tr><tr><td>Death within 1 year</td><td>13.0%</td><td>12.4%</td><td>0.64</td></tr><tr><td>Reinfarction</td><td>4.3%</td><td>2.5%</td><td>0.01</td></tr><tr><td>Recurrent ischaemia/angina</td><td>14.9%</td><td>11.8%</td><td>0.01</td></tr></tbody></table></div></div></span></p></div><div><h3>Authors’ conclusions</h3><p>Although treatment with reteplase plus abciximab did not provide a survival benefit for people with diabetes and ST-segment elevation myocardial infarction compared with reteplase alone, nonfatal outcomes including reinfarction and recurrent ischaemia were substantially reduced.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 230-231"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"H. pylori eradication does not reduce gastric cancer incidence in a high-risk area of China","authors":"Bor-Shyang Sheu MD (Commentary Author),&nbsp;Xi-Zhang Lin MD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.005","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.005","url":null,"abstract":"<div><h3>Question</h3><p>Does treating <em>H. Pylori</em> reduce the incidence of gastric cancer?</p></div><div><h3>Study</h3><p>Randomised placebo-controlled trial.</p></div><div><h3>Main results</h3><p>At 7.5 years, incidence of gastric cancer was not significantly different between groups (treatment: 0.86%, <em>n=</em>7; placebo: 1.35%, <em>n</em>=11; <em>p</em>=0.33). In people without precancerous lesions at baseline, risk of gastric cancer was significantly lower for treatment compared with placebo (incidence of gastric cancer: treatment <em>n</em>=0; placebo <em>n</em>=6; <em>p</em>=0.02) but there was no difference among people with precancerous lesions (<em>n</em>=7 and 5, respectively). Smoking (hazard ratio [HR] 6.2, 95% CI 2.3 to 16.5) and older age (HR per 1 year 1.10, 95% CI 1.05 to 1.15) were independent predictors of gastric cancer risk.</p></div><div><h3>Authors’ conclusions</h3><p>Incidence of gastric cancer was similar between <em>H. pylori</em> eradication and placebo groups over 7.5 years of follow-up. However, it was significantly reduced in a subgroup of people without precancerous lesions at baseline.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 218-220"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.005","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823711","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Unscheduled care for people with asthma in a multi-ethnic area is reduced following educational outreach programme by specialist nurses☆","authors":"A. Kamps","doi":"10.1016/J.EHBC.2004.05.017","DOIUrl":"https://doi.org/10.1016/J.EHBC.2004.05.017","url":null,"abstract":"","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"68 1","pages":"190-191"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"74951044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"No association between mobile phone usage and development of acoustic neuroma","authors":"Lennart Hardell MD, PhD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.007","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.007","url":null,"abstract":"<div><h3>Question</h3><p>Is the incidence of acoustic neuroma associated with mobile phone usage?</p></div><div><h3>Study design</h3><p>Population-based case-control study.</p></div><div><h3>Main results</h3><p>Risk of acoustic neuroma was not statistically higher among people regularly using mobile phones compared with those who never or rarely using one (OR 0.90, 95% CI 0.51 to 1.57). No increased risk was associated with the length of time since beginning regular use of mobile phones, total duration or number of calls (see Table 1). In people with acoustic neuroma, mean tumour size was bigger in regular mobile phone users (1.66<!--> <!-->cm³) than non-users (1.39<!--> <!-->cm³) (Wilcoxon, <em>p</em>=0.03) but the increased risk of developing a large tumour (⩾1.51<!--> <!-->cm³) was not statistically significant (OR 1.87, 95% CI 0.75 to 4.64).</p></div><div><h3>Authors’ conclusions</h3><p>Mobile phone usage is not positively associated with the development of acoustic neuroma, regardless of the estimated total duration or number of calls, or the length of time since regular use began.<span><div><div><table><tbody><tr><td><strong>Table 1</strong> Odds of developing acoustic neuroma according to mobile phone usage</td></tr><tr><td>Time since beginning of regular usage</td><td>OR</td><td>95% CI</td></tr><tr><td>Never/rarely used/&lt;1 year</td><td>1.00</td><td></td></tr><tr><td>1 to 4 years</td><td>0.86</td><td>0.45 to 1.62</td></tr><tr><td>⩾5 years</td><td>0.68</td><td>0.32 to 1.44</td></tr><tr><td>5 to 9 years</td><td>0.86</td><td>0.39 to 1.93</td></tr><tr><td>⩾10 years</td><td>0.22</td><td>0.04 to 1.11</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Life time cumulative number of calls</td><td></td><td></td></tr><tr><td>Never/rarely used</td><td>1.00</td><td></td></tr><tr><td>⩽2975</td><td>0.99</td><td>0.53 to 1.83</td></tr><tr><td>2975 to 11<!--> <!-->550</td><td>0.79</td><td>0.32 to 1.92</td></tr><tr><td>&gt;11<!--> <!-->550</td><td>0.72</td><td>0.28 to 1.87</td></tr><tr><td></td><td></td><td></td></tr><tr><td>Life time cumulative hours of use</td><td></td><td></td></tr><tr><td>Never/rarely used</td><td>1.00</td><td></td></tr><tr><td>⩽167.5</td><td>0.93</td><td>0.49 to 1.74</td></tr><tr><td>&gt;167.5 to 654</td><td>1.01</td><td>0.43 to 2.38</td></tr><tr><td>&gt;1654</td><td>0.66</td><td>0.25 to 1.74</td></tr></tbody></table></div></div></span></p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 213-215"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.007","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823695","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Hormone replacement therapy is not safe for breast cancer survivors","authors":"Rena Vassilopoulou-Sellin MD (Commentary Author)","doi":"10.1016/j.ehbc.2004.05.004","DOIUrl":"https://doi.org/10.1016/j.ehbc.2004.05.004","url":null,"abstract":"<div><h3>Question</h3><p>Is hormone replacement therapy safe for women with previous breast cancer?</p></div><div><h3>Study design</h3><p>Randomised controlled trial (interim analysis).</p></div><div><h3>Main results</h3><p>In 345 women surviving breast cancer, there were more new breast cancer events in women taking HRT for menopausal symptoms compared with women receiving symptomatic treatment without hormones at a median of 2 years follow-up (absolute risk for new breast cancer: 26/174 [14%] with HRT vs 8/171 [5%] with no HRT; relative hazard 3.5, 95% CI 1.5 to 8.1).</p></div><div><h3>Authors’ conclusions</h3><p>In women surving breast cancer, those who received HRT for menopausal symptoms were at a higher risk of developing new breast cancers compared with those who received symptomatic treatment without hormones. These findings led to the termination of the trial.</p></div>","PeriodicalId":100512,"journal":{"name":"Evidence-based Healthcare","volume":"8 4","pages":"Pages 224-226"},"PeriodicalIF":0.0,"publicationDate":"2004-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.ehbc.2004.05.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"71823707","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}